This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diefenbacher, M. Articles by Kassel, O. Search for Related Content PubMed PubMed Citation Articles by Diefenbacher, M. Articles by Kassel, O.

Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1

Forschungszentrum Karlsruhe (M.D., S.S., C.H., J.V.M., M.L., P.H., O.K.), Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany; Department of Molecular Cell Biology (H.v.D.), Leiden University Medical Center, 2333AL Leiden, The Netherlands; Université de Lyon (M.C.), Institut National de la Santé et de la Recherche Médicale, Unité 758, Institut Fédératif de Recherche 128, Lyon-Gerland, France; and Leibniz Institute of Age Research-Fritz-Lipmann-Institute (P.H.), D-07745 Jena, Germany

Address all correspondence and requests for reprints to: Olivier Kassel, Institut für Toxikologie und Genetik, Forschungszentrum Karlsruhe, Hermann-von-Helmholtz Platz 1, D- 76344 Eggenstein-Leopoldshafen, Germany. E-mail: Olivier.Kassel{at}itg.fzk.de.

The term activator protein (AP)-1 describes homodimeric and heterodimeric transcription factors composed of members of the Jun, Fos, and cAMP response element-binding protein (CREB)/activating transcription factor (ATF) families of proteins. Distinct AP-1 dimers, for instance the prototypical c-Jun:c-Fos and c-Jun:ATF2 dimers, are differentially regulated by signaling pathways and bind related yet distinct response elements in the regulatory regions of AP-1 target genes. Little is known about the dimer-specific regulation of AP-1 activity at the promoter of its target genes. We have previously shown that nTrip6, the nuclear isoform of the LIM domain protein Trip6, acts as an AP-1 coactivator. Moreover, nTrip6 is an essential component of glucocorticoid receptor (GR)-mediated trans-repression of AP-1, in that it mediates the tethering of GR to the promoter-bound AP-1. We have now discovered a striking specificity of nTrip6 actions determined by the binding preference of its LIM domains. We show that nTrip6 interacts only with Fos family members. Consequently, nTrip6 is a selective coactivator for AP-1 dimers containing Fos. nTrip6 also assembles activated GR to c-Jun:c-Fos-driven promoters. Neither nTrip6 nor GR are recruited to a promoter occupied by c-Jun:ATF2. Thus, only Fos-containing dimers are trans-repressed by GR. Thus, the dimer composition of AP-1 determines the mechanism of both the positive and negative regulation of AP-1 transcriptional activity. Interestingly, on a second level of action, GR represses the increase in transcriptional activity of c-Jun:ATF2 induced by c-Jun N-terminal kinase (JNK)-dependent phosphorylation. This repression depends on GR-mediated induction of MAPK phosphatase 1 (MKP-1) expression, which results in c-Jun N-terminal kinase inactivation.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR

Ligands:   Dexamethasone

This article has been cited by other articles:

				E. M. King, N. S. Holden, W. Gong, C. F. Rider, and R. Newton Inhibition of NF-{kappa}B-dependent Transcription by MKP-1: TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK J. Biol. Chem., September 25, 2009; 284(39): 26803 - 26815. [Abstract] [Full Text] [PDF]

				S. Harada, M. Uchida, and N. Shimizu Episomal High Copy Number Maintenance of Hairpin-capped DNA Bearing a Replication Initiation Region in Human Cells J. Biol. Chem., September 4, 2009; 284(36): 24320 - 24327. [Abstract] [Full Text] [PDF]

				K. De Bosscher and G. Haegeman Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids Mol. Endocrinol., March 1, 2009; 23(3): 281 - 291. [Abstract] [Full Text] [PDF]

				K.-i. Utani and N. Shimizu How transcription proceeds in a large artificial heterochromatin in human cells Nucleic Acids Res., February 1, 2009; 37(2): 393 - 404. [Abstract] [Full Text] [PDF]